These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7557659)

  • 21. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients.
    Beal K; Allen L; Yahalom J
    Cancer; 2006 Jun; 106(12):2652-6. PubMed ID: 16700039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Choice of therapy and overall survival in patients with chronic myeloproliferative diseases].
    Rukavitsyn OA; Pop VP; Seriakov AP
    Vopr Onkol; 2004; 50(4):435-9. PubMed ID: 15605767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A clinical study of sixteen polycythemia vera cases--acute myeloblastic leukemia in patients with polycythemia vera].
    Takeyama H; Shimokawa T; Yamada H; Watanabe E
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2833-7. PubMed ID: 7993124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data.
    Ghirardi A; Carobbio A; Masciulli A; Barbui T
    Blood Cancer J; 2018 Jan; 8(1):5. PubMed ID: 29335456
    [No Abstract]   [Full Text] [Related]  

  • 25. A contemporary approach to the diagnosis and management of polycythemia vera.
    Tefferi A
    Curr Hematol Rep; 2003 May; 2(3):237-41. PubMed ID: 12901345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of polycythemia vera.
    Barbui T; Finazzi G
    Haematologica; 1998 Feb; 83(2):143-9. PubMed ID: 9549926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.
    Passamonti F; Malabarba L; Orlandi E; Baratè C; Canevari A; Brusamolino E; Bonfichi M; Arcaini L; Caberlon S; Pascutto C; Lazzarino M
    Haematologica; 2003 Jan; 88(1):13-8. PubMed ID: 12551821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expertise-based management in essential thrombocythemia and polycythemia vera.
    Finazzi G; Barbui T
    Cancer J; 2007; 13(6):372-6. PubMed ID: 18032974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of polycythemia vera with recombinant interferon alpha (rIFNalpha) or imatinib mesylate.
    Silver RT
    Curr Hematol Rep; 2005 May; 4(3):235-7. PubMed ID: 15865878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycythemia vera and pregnancy: experience of four pregnancies in a single patient.
    Aggarwal N; Chopra S; Suri V; Sikka P; Goundan A; Malhotra P
    Arch Gynecol Obstet; 2011 Feb; 283(2):393-5. PubMed ID: 20358212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients.
    Bachleitner-Hofmann T; Grumbeck E; Gisslinger H
    Thromb Res; 2003; 112(4):229-32. PubMed ID: 14987916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk-adapted therapy in essential thrombocythemia and polycythemia vera.
    Finazzi G; Barbui T
    Blood Rev; 2005 Sep; 19(5):243-52. PubMed ID: 15963833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycythemia vera and the emperor's new clothes.
    Spivak JL
    Haematologica; 2003 Jan; 88(1):1-4. PubMed ID: 12551817
    [No Abstract]   [Full Text] [Related]  

  • 34. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
    Marchioli R; Finazzi G; Landolfi R; Kutti J; Gisslinger H; Patrono C; Marilus R; Villegas A; Tognoni G; Barbui T
    J Clin Oncol; 2005 Apr; 23(10):2224-32. PubMed ID: 15710945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based management of polycythemia vera.
    Barbui T; Finazzi G
    Best Pract Res Clin Haematol; 2006; 19(3):483-93. PubMed ID: 16781485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Polyglobulia vera. Difficulties and complications of treatment by phlebotomy].
    Arrago JP; Rain JD; Dresch C; Najean Y
    Presse Med; 1987 Feb; 16(6):291-4. PubMed ID: 2950464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal life expectancy for polycythemia vera (PV) patients is possible.
    Abu-Zeinah G; Silver RT; Abu-Zeinah K; Scandura JM
    Leukemia; 2022 Feb; 36(2):569-572. PubMed ID: 34625712
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnosis and therapy of polycythemia vera.
    Lengfelder E; Merx K; Hehlmann R
    Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycythemia vera.
    Stuart BJ; Viera AJ
    Am Fam Physician; 2004 May; 69(9):2139-44. PubMed ID: 15152961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk.
    Barbui T; Finazzi G
    Semin Thromb Hemost; 2007 Jun; 33(4):321-9. PubMed ID: 17525889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.